129 related articles for article (PubMed ID: 17542455)
21. Hepatitis C testing in sexual health services in England, 2002-7: results from sentinel surveillance.
Tweed E; Brant L; Hurrelle M; Klapper P; Ramsay M;
Sex Transm Infect; 2010 Apr; 86(2):126-30. PubMed ID: 19858534
[TBL] [Abstract][Full Text] [Related]
22. The cost of implementing rapid HIV testing in sexually transmitted disease clinics in the United States.
Eggman AA; Feaster DJ; Leff JA; Golden MR; Castellon PC; Gooden L; Matheson T; Colfax GN; Metsch LR; Schackman BR
Sex Transm Dis; 2014 Sep; 41(9):545-50. PubMed ID: 25118967
[TBL] [Abstract][Full Text] [Related]
23. HCV and HIV counseling and testing integration in California: an innovative approach to increase HIV counseling and testing rates.
Stopka TJ; Marshall C; Bluthenthal RN; Webb DS; Truax SR
Public Health Rep; 2007; 122 Suppl 2(Suppl 2):68-73. PubMed ID: 17542457
[TBL] [Abstract][Full Text] [Related]
24. An assessment of care provided by a public sector STD clinic in Cape Town.
Mathews C; van Rensburg A; Schierhout G; Coetzee N; Lombard CJ; Fehler HG; Ballard RC
Int J STD AIDS; 1998 Nov; 9(11):689-94. PubMed ID: 9863583
[TBL] [Abstract][Full Text] [Related]
25. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
Kim SY; Billah K; Lieu TA; Weinstein MC
Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
[TBL] [Abstract][Full Text] [Related]
26. Quality of sexually transmitted disease services in Jamaica: evaluation of a clinic-based approach. Collaborative Working Group on Indicators of STD Case Management.
Bryce J; Vernon A; Brathwaite AR; Perry S; Figueroa JP; Emerson RB
Bull World Health Organ; 1994; 72(2):239-47. PubMed ID: 8205644
[TBL] [Abstract][Full Text] [Related]
27. Costs and cost-effectiveness of different follow-up schedules for detection of occupational hepatitis C virus infection.
Deuffic-Burban S; Abiteboul D; Lot F; Branger M; Bouvet E; Yazdanpanah Y
Gut; 2009 Jan; 58(1):105-10. PubMed ID: 18824553
[TBL] [Abstract][Full Text] [Related]
28. Differences in demographics and risk factors among men attending public v non-public STD clinics in Baltimore, Maryland.
Porter CA; Thompson D; Erbelding EJ
Sex Transm Infect; 2004 Dec; 80(6):488-91. PubMed ID: 15572621
[TBL] [Abstract][Full Text] [Related]
29. Public health departments providing sexually transmitted disease services.
Landry DJ; Forrest JD
Fam Plann Perspect; 1996; 28(6):261-6. PubMed ID: 8959416
[TBL] [Abstract][Full Text] [Related]
30. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS
Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248
[TBL] [Abstract][Full Text] [Related]
31. High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic.
Kieran J; Dillon A; Farrell G; Jackson A; Norris S; Mulcahy F; Bergin C
Int J STD AIDS; 2011 Oct; 22(10):571-6. PubMed ID: 21998177
[TBL] [Abstract][Full Text] [Related]
32. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
33. The costs of not treating hepatitis C virus infection in injecting drug users in New Zealand.
Sheerin IG; Green FT; Sellman JD
Drug Alcohol Rev; 2003 Jun; 22(2):159-67. PubMed ID: 12850902
[TBL] [Abstract][Full Text] [Related]
34. Self-reported hepatitis C virus antibody status and risk behavior in young injectors.
Hagan H; Campbell J; Thiede H; Strathdee S; Ouellet L; Kapadia F; Hudson S; Garfein RS
Public Health Rep; 2006; 121(6):710-9. PubMed ID: 17278406
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of and risk factors for hepatitis C virus infection among STD clinic clientele in Miami, Florida.
Weisbord JS; Trepka MJ; Zhang G; Smith IP; Brewer T
Sex Transm Infect; 2003 Feb; 79(1):E1. PubMed ID: 12576631
[TBL] [Abstract][Full Text] [Related]
36. Uptake of hepatitis C screening, characteristics of patients tested, and intervention costs in the BEST-C study.
Brady JE; Liffmann DK; Yartel A; Kil N; Federman AD; Kannry J; Jordan C; Massoud OI; Nerenz DR; Brown KA; Smith BD; Vellozzi C; Rein DB
Hepatology; 2017 Jan; 65(1):44-53. PubMed ID: 27770543
[TBL] [Abstract][Full Text] [Related]
37. Continuing Need for Sexually Transmitted Disease Clinics After the Affordable Care Act.
Hoover KW; Parsell BW; Leichliter JS; Habel MA; Tao G; Pearson WS; Gift TL
Am J Public Health; 2015 Nov; 105 Suppl 5(Suppl 5):S690-5. PubMed ID: 26447908
[TBL] [Abstract][Full Text] [Related]
38. Economic benefits of hepatitis B vaccination at sexually transmitted disease clinics in the U.S.
Miriti MK; Billah K; Weinbaum C; Subiadur J; Zimmerman R; Murray P; Gunn R; Buffington J
Public Health Rep; 2008; 123(4):504-13. PubMed ID: 18763413
[TBL] [Abstract][Full Text] [Related]
39. Clinical pathways for patients with newly diagnosed hepatitis C - what actually happens.
Irving WL; Smith S; Cater R; Pugh S; Neal KR; Coupland CA; Ryder SD; Thomson BJ; Pringle M; Bicknell M; Hippisley-Cox J
J Viral Hepat; 2006 Apr; 13(4):264-71. PubMed ID: 16611193
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population.
Salomon JA; Weinstein MC; Hammitt JK; Goldie SJ
JAMA; 2003 Jul; 290(2):228-37. PubMed ID: 12851278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
